You are viewing the site in preview mode

Skip to main content

Table 2 Treatments used in 44 patients with cluster headache

From: Cluster headache and galcanezumab: the first real-world Brazilian study and an expert consensus on its use among other treatments

Variables

Frequency

(n; %)

Did they start steroid treatment?

 

 Yes

42 (96.0)

 No

2 (4.0)

Did they start treatment with other drugs?

 

 Verapamil

11 (25.0)

 Lithium

4 (9.0)

 Verapamil plus lithium

3 (7.0)

 Galcanezumab

44 (100.0)

Prescribed dose of galcanezumab

 

 240 mg

8 (18.0)

 300 mg

29 (66.0)

 360 mg

7 (16.0)

Number of times that used galcanezumab

 

 Once

24 (54.5)

 Twice

9 (20.5)

 ≥ Three times

4 (9.1)

 Lost to follow-up

7 (15.9)

Reduction of attacks ≥ 50% after 3 weeks

 

 Yes

29 (66.0)

 No

8 (18.0)

 Lost to follow-up

7 (16.0)